Avantor Investor Day Presentation Deck
Strengthening offerings in high-growth workflows
ADVANCED
MODALITY¹
LC-MS FOR
CHARACTERIZATION OF
ADVANCED MODALITIES
SAMPLE
COLLECTION
Navantor™
Brands
Proprietary &
Third-Party
Products
PIPELINE GROWTH
~20%+
VWROAD
CAGR
SAMPLE
PREPARATION
J.T.Baker
CELLULAR ANALYSIS FOR
TRANSLATIONAL
RESEARCH
ritter
SAMPLE
ANALYSIS
1. Advanced modalities include Cell & Gene Therapy, Antibody Drug Conjugates, and Nucleic Acid Therapeutics. CAGR represents 2021 - 2026.
2. Cell analysis techniques include flow cytometry, PCR, cell microarray, high-content screening, etc. CAGR represents 2023 - 2028.
Figures based on management estimates.
HichromⓇ
2
CELL
ANALYSIS²
MARKET
~10%+
UltrasphereⓇ
Lab Chemicals, Cell Culture Media, Buffers, Growth Factors, Reagents, Extraction Kits, PPE,
Filters, Plastic Consumables, Liquid-Handling Solutions, Biorepository and Storage Solutions,
Columns, Measuring Apparatus, Analytical Instruments, Accessories
ACCELERATING
PROFITABLE GROWTH
ACEⓇ PartiSphere® PartisilⓇ
CAGR
Navantor™
37View entire presentation